Journal article
The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy
Abstract
AIMS: The aim of this study was to assess the effect of the angiotensin converting enzyme inhibitor perindopril on cardiovascular events in diabetic patients with coronary artery disease.
METHODS AND RESULTS: A total of 1502 diabetic patients with known coronary artery disease and without heart failure of 12 218 overall in the EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery (EUROPA) disease were …
Authors
Daly CA; Fox KM; Remme WJ; Bertrand ME; Ferrari R; Simoons ML
Journal
European Heart Journal, Vol. 26, No. 14, pp. 1369–1378
Publisher
Oxford University Press (OUP)
Publication Date
July 1, 2005
DOI
10.1093/eurheartj/ehi225
ISSN
0195-668X